Source: Cision Canada

Press Release: Jamp Pharma : JAMP Pharma Launches SIMLANDI , a NEW High-Concentration, Low Volume, Citrate-Free formulation, Biosimilar to Humira, in Canada

/CNW/ - JAMP Pharma Group ("JAMP Pharma"), a Canadian-owned pharmaceutical company headquartered in the Montreal area, announced today the launch of SIMLANDI ,...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Louis Pilon's photo - President & CEO of Jamp Pharma

President & CEO

Louis Pilon

CEO Approval Rating

80/100

Read more